By Kate Birch, Pamela Brown, and Miran Farah
Reprinted with permission from Similia: The Australian Journal of Homoeopathic Medicine and The Australian Homoeopathic Association: Originally published in Similia 2025, Volume 38 no. 2, p34-42 and reprinted with permission. (Please note English spelling throughout)
Abstract
Keywords: microbiome, dysbiosis, bowel nosodes,
homoeoprophylaxis, homeopathy
This retrospective case series analysed the short
and long-term health outcomes of a novel Healthy
Biome HPx Program and built homoeopathic clinical
indications for each nosode used in the program.
Insight into the remedy responses were obtained from
the degree and nature of the individual’s response to
the nosode and their preexisting health profile. The
program registered 65 families of which 11 participated
in this study. Nine nosodes in 1M potency were given
under the supervision of a certified HPx practitioner.
One respondent had marked improvement of all
health conditions; 55% responded with significant
improvement of health and resolution of most issues,
18% reported a relapse of symptoms after six or seven
months, 18% noted some improvement, and 9% did
not experience any improvement in health. No adverse
effects were reported. The findings indicate when
the individual and their biome is in balance, marked
improvements in wellbeing and vitality are experienced.
This suggests that the sequential dosing of nosodes
related to the microbiome has advantageous effects.
The Healthy Biome HPx Program warrants further
research to garner deeper understanding of the clinical
indications and potential beneficial role each nosode
plays in the health of the individual.
Read more here: Retrospective Case Serries on Biome Homoeoprophylaxis (HPx)


